Advancing Clinical Trial Quality: Tools, Insights, and Innovations

At TRI, we are dedicated to empowering all stakeholders in quality management by providing the most pertinent and effective tools to simplify RBQM for all clinical trials.

In this issue, we are thrilled to unveil a collection of innovative tools and resources tailored to enhance your quality management processes. We have also gathered key insights and significant updates from recent regulatory events to keep you informed.

5 Minutes, 5 Questions Video Interview Series (#5M5Q) Returns for its Second Season, this time with a Spotlight on RBQM

Kicking off our 2024 series, don’t miss our latest episode featuring an engaging conversation with Miguel Valenzuela, Associate Director of Clinical Operations at Alnylam Pharmaceuticals. With extensive expertise in risk management, business intelligence, and analytics, Miguel brings extensive insights into RBQM strategies and practices.

Tune in to explore the future of clinical research through the eyes of one of the leading #RBQM practitioners. Watch the full interview now and dive deep into the innovations shaping our industry.

Are you passionate about quality management in clinical research? Do you have insights to share? We would love to hear from you! Please reach out to Gemma Telfer at [email protected] to discuss the possibility of featuring in an upcoming interview.

Register for Complimentary Access to TRI’s Premium GCP e-Learning Course

In our journey to set new standards in clinical trial excellence, we're excited to offer you, as a leader at your Sponsor or CRO organization, complimentary access to our premium GCP e-learning course. This opportunity isn't just for you; it extends to your entire team, allowing you to collectively deepen your understanding of GCP principles within your organization. Crafted by TRI's regulatory experts, this interactive course is your gateway to mastering the intricacies of trial conduct, ensuring your trials not only meet but surpass industry benchmarks. Embrace this chance to elevate your team's capabilities and lead the charge in advancing clinical trial quality.

Why Choose Our Course?

This offering is far from a basic e-learning module; it is an immersive journey designed to transform your comprehension of GCP, setting a new standard for professional development in the field.

• Complimentary Access: We are offering exclusive access to this premium content at no cost for a limited period.
• Self-Paced Learning: This course offers the flexibility to accommodate your schedule, allowing you to progress at a pace that suits.
• Interactive Learning: The course's interactive design ensures an engaging exploration of GCP principles.
• Certification: Receive a certificate upon completion, marking your newfound expertise in GCP.

How does it work?

We invite you to enroll up to 2 members of your management team, to evaluate whether you would like us to extend access to your department. Should you choose to extend access, this will also remain complementary.

Embark on a journey to redefine the quality of clinical trials and elevate your professional capabilities. Enroll in our Interactive GCP e-Learning Course today and mark the beginning of your path to excellence.

Register for complimentary access

Operationalizing RBQM: Insights and Actions for Enhanced Efficiency [Upcoming Webinar]

Join Duncan Hall , CEO of TRI - The RBQM Experts , and Amandeep Sonik , Senior Director of RBQM at Worldwide Clinical Trials , for an enlightening webinar on transforming the theoretical concepts of RBQM into practical, actionable strategies. This session will demonstrate how effective RBQM operationalization mitigates risks, enhances patient safety, and improves clinical trial outcomes. By participating, you will emerge with a comprehensive understanding of the operationalization process, equipped with the insights and actions to streamline RBQM operationalization for your organization.

Key discussion points

• RBQM Operationalization: A clear explanation of what RBQM operationalization is and the characteristics of what effective operationalization looks like.
• Proactive risk mitigation: Through the nuanced assessment of potential risks and the strategic implementation of targeted actions designed to neutralize the risks that matter.
• Change management: Attributes of the stakeholders engaged in RBQM, and the technological advancements necessary to drive its operationalization.
• Real-world evidence: Hear about actual case studies where RBQM principles have been successfully applied, leading to significant improvements in trial management and outcomes.

We encourage you to extend this invitation to colleagues and professionals within your network who could benefit from these ground-breaking insights. Together, let's pave the way for a more efficient and effective implementation of RBQM in clinical trials, setting new standards for excellence in the field.

Register for this complimentary webinar

FDA On Clinical Trial Innovation and Regulatory Evolution, Insights from The Clinical Trial Vanguard

Dive into the transformative world of clinical trials with Moe Alsumidaie's incisive analysis on the recent "Enhancing Adoption of Innovative Clinical Trial Approaches" conference, organized by the Duke-Margolis Institute for Health Policy Institute for Health Policy. This landmark event featured a high-caliber lineup of experts, including the FDA's own Patrizia Cavazzoni, discussing innovative approaches to drug evaluation and research. Learn how the FDA is reshaping its processes to improve efficiency and adaptability while maintaining its stringent safety standards. The conference highlighted the FDA’s strategic embrace of real-world data and its efforts to enhance cross-sector collaborations, heralding a new era in regulatory frameworks. Don’t miss this critical overview of ongoing regulatory evolution.

Read the article